Table 3 RCC-specific mean survivals for serotonin, CD56 and NSE.
From: Evaluation of neuroendocrine markers in renal cell carcinoma
Marker | Immunoreactivity | Survival, months (95% CI) | p-value |
|---|---|---|---|
serotonin | positive | 176 (138-214) | 0.3 |
| Â | negative | 148 (133-163) | Â |
CD56 | positive | 139 (106-172) | 0.4 |
| Â | negative | 156 (140-172) | Â |
NSE | positive | 149 (127-171) | 0.8 |
| Â | negative | 153 (134-171) | Â |